Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000932 · ClinicalTrials.gov registry record
A Study of the Long-Term Outcomes of HIV-Positive Patients
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 3,669
- Enrollment target
NCT00000932 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 3,669 participants.
The verdict
NCT00000932 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 3,669 participants
- Enrollment target
Study Summary
The purpose of this study is to collect information about life spans and HIV-related illnesses in multiple groups of HIV-positive patients with varying anti-HIV treatment experience, including no treatment at all. Anti-HIV treatment has been successful in slowing disease progression in many patients. However, there are still questions regarding the best way to use anti-HIV drugs. This study is designed to provide long-term monitoring of patients who have already received anti-HIV treatment as well as patients who are just beginning treatment or have decided not to receive treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,669 participants |
| Start Date | 1999-03 |
| Est. Completion | 2006-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000932
The ClinicalTrials.gov registry entry for NCT00000932 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,669 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00000932 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000932 about?
NCT00000932 is a clinical study titled "A Study of the Long-Term Outcomes of HIV-Positive Patients". The purpose of this study is to collect information about life spans and HIV-related illnesses in multiple groups of HIV-positive patients with varying anti-HIV treatment experience, including no treatment at all. Anti-HIV treatment has been successful in slowing disease progression in many patient...
What is the current status of trial NCT00000932?
This trial is currently completed. The enrollment target is 3,669 participants. The study started on 1999-03. Estimated completion is 2006-09.
Who is sponsoring clinical trial NCT00000932?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.